TP53 and neoplasm: How the genetic alteration of TP53 promoted tumor aggressiveness via multiple regulatory means, including miRNA, glycosylation, subcellular localization, and metabolism, on the MGAT4A‐related signaling axis, has been demonstrated in EC.